Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability?Investors Business Daily • 06/30/25
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shotCNBC • 06/30/25
Moderna (MRNA) Advances While Market Declines: Some Information for InvestorsZacks Investment Research • 06/20/25
Moderna, Inc. (MRNA) Presents at Barclays Speaking the Science Call Series TranscriptSeeking Alpha • 06/16/25
Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospectsReuters • 06/13/25
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV DiseaseAccesswire • 06/12/25
Moderna, Inc. (MRNA) Presents at Goldman Sachs 46th Annual Global Healthcare Conference TranscriptSeeking Alpha • 06/12/25
Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025Accesswire • 06/11/25
RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts sayCNBC • 06/10/25
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-upReuters • 06/10/25